2025 annual financial data
NovaBridge Biosciences 2025 Operating margin
NovaBridge Biosciences 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -13,476,696 USD and net income was -6,614,616 USD.
Operating cash flow was -20,597,000 USD.
Get free NovaBridge Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,476,696 USD
- Net income
- -6,614,616 USD
- Operating cash flow
- -20,597,000 USD